Format

Send to

Choose Destination
See comment in PubMed Commons below
J Hepatol. 2014 Feb;60(2):457-60. doi: 10.1016/j.jhep.2013.10.008. Epub 2013 Oct 17.

The use of hemospray in portal hypertensive bleeding; a case series.

Author information

  • 1Department of Gastroenterology, Glasgow Royal Infirmary, United Kingdom. Electronic address: Lynsmith1@nhs.net.
  • 2Department of Gastroenterology, Glasgow Royal Infirmary, United Kingdom.

Abstract

Hemospray is a haemostatic agent licensed for endoscopic haemostasis of non-variceal upper gastrointestinal bleeding (NVUGIB) in Europe and Canada. Hemospray has been shown to be safe and effective in achieving haemostasis in bleeding peptic ulcers in a prospective clinical study and several further case series have described the use of hemospray in other non-variceal causes of gastrointestinal bleeding. Portal hypertensive gastropathy and colopathy are common in patients with portal hypertension. As hemospray is an easy to apply, non-contact method, which can cover large areas of mucosa, it may be of benefit in acute non-variceal portal hypertensive bleeding. We present data from the first four consecutive patients presenting to our institution with acute haemorrhage secondary to non-variceal diffuse portal hypertensive bleeding treated with hemospray.

Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

KEYWORDS:

Endoscopic hemostasis; Gastrointestinal bleeding; Portal hypertension

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk